Relapsed Refractory R R Diffuse Large B Cell Lymphoma clinical trials

Explore recruiting relapsed refractory r r diffuse large b cell lymphoma clinical trials.

Recruiting relapsed refractory r r diffuse large b cell lymphoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Relapsed Refractory R R Diffuse Large B Cell Lymphoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A first-in-human, open-label, clinical study to assess the safety, tolerability, and activity of OT-C001 (amplified/activated allogenic natural killer cells) in patients with relapsed/refractory diffuse large B-cell lymphoma

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Relapsed Refractory R R Diffuse Large B Cell Lymphoma trials by city

Relapsed Refractory R R Diffuse Large B Cell Lymphoma in Toronto Relapsed Refractory R R Diffuse Large B Cell Lymphoma in Vancouver Relapsed Refractory R R Diffuse Large B Cell Lymphoma in Montreal Relapsed Refractory R R Diffuse Large B Cell Lymphoma in Calgary Relapsed Refractory R R Diffuse Large B Cell Lymphoma in Edmonton Relapsed Refractory R R Diffuse Large B Cell Lymphoma in Ottawa Relapsed Refractory R R Diffuse Large B Cell Lymphoma in Winnipeg Relapsed Refractory R R Diffuse Large B Cell Lymphoma in Quebec City Relapsed Refractory R R Diffuse Large B Cell Lymphoma in Hamilton Relapsed Refractory R R Diffuse Large B Cell Lymphoma in Kitchener Relapsed Refractory R R Diffuse Large B Cell Lymphoma in London Relapsed Refractory R R Diffuse Large B Cell Lymphoma in Halifax Relapsed Refractory R R Diffuse Large B Cell Lymphoma in New York Relapsed Refractory R R Diffuse Large B Cell Lymphoma in Los Angeles Relapsed Refractory R R Diffuse Large B Cell Lymphoma in Chicago Relapsed Refractory R R Diffuse Large B Cell Lymphoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease